Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Biohaven Pharmaceutical Holding Company Ltd
Total Liabilities
Biohaven Pharmaceutical Holding Company Ltd
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
|
Total Liabilities
$85.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities
$140.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities
$38.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities
$88B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities
$5.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Liabilities
$7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
See Also
What is Biohaven Pharmaceutical Holding Company Ltd's Total Liabilities?
Total Liabilities
85.2m
USD
Based on the financial report for Dec 31, 2023, Biohaven Pharmaceutical Holding Company Ltd's Total Liabilities amounts to 85.2m USD.
What is Biohaven Pharmaceutical Holding Company Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 3Y
-3%
Over the last year, the Total Liabilities growth was -31%. The average annual Total Liabilities growth rates for Biohaven Pharmaceutical Holding Company Ltd have been -3% over the past three years .